CapWealth Advisors’s Eli Lilly LLY Stock Holding History

CapWealth Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.1M	Buy	9,226 +311	+3%	+$318K	0.76%	47
2026 Q1	$8.2M	Buy	8,915 +8,534	+2,240%	+$8.65M	0.61%	51
2025 Q4	$409K	Buy	381 +3	+0.8%	+$2.87K	0.03%	99
2025 Q3	$288K	Sell	378 -15	-4%	-$11.2K	0.02%	103
2025 Q2	$306K	Sell	393 -69	-15%	-$53.6K	0.03%	88
2025 Q1	$382K	Buy	462 +19	+4%	+$15.8K	0.04%	79
2024 Q4	$342K	Hold	443	–	–	0.04%	82
2024 Q3	$392K	Buy	443 +5	+1%	+$4.5K	0.04%	80
2024 Q2	$397K	Buy	438 +15	+4%	+$12K	0.05%	71
2024 Q1	$329K	Hold	423	–	–	0.04%	77
2023 Q4	$247K	Hold	423	–	–	0.03%	90
2023 Q3	$227K	Buy	+423	New	+$218K	0.03%	98
2014 Q3	–	Sell	-300	Closed	-$19K	–	377
2014 Q2	$19K	Sell	300 -125	-29%	-$7.46K	﹤0.01%	193
2014 Q1	$25K	Hold	425	–	–	0.01%	179
2013 Q4	$22K	Hold	425	–	–	0.01%	201
2013 Q3	$21K	Hold	425	–	–	0.01%	235
2013 Q2	$21K	Buy	+425	New	+$23.1K	0.01%	221

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CapWealth Advisors's LLY Position: Q2 2026 in Review

CapWealth Advisors increased its Eli Lilly (LLY) stake by 3.5% in Q2 2026, buying an estimated $318K and bringing the position to 9,226 shares worth $11.1M. The position accounts for 0.76% of the portfolio, ranked #47.

CapWealth Advisors first reported a position in LLY in Q2 2013 and has held it in 17 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

CapWealth Advisors held 9,226 shares of Eli Lilly worth $11.1M as of Q2 2026.
CapWealth Advisors bought 311 Eli Lilly shares in Q2 2026, an estimated $318K.
Eli Lilly made up 0.76% of CapWealth Advisors's portfolio in Q2 2026, its #47 holding.
CapWealth Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 17 quarters since.
4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on CapWealth Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.